Thymic stroma and TFII-I: towards new targeted therapies.

Saved in:
Bibliographic Details
Title: Thymic stroma and TFII-I: towards new targeted therapies.
Authors: Manti PG; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy. Electronic address: Pierluigi.manti@ieo.it., Trattaro S; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy., Castaldi D; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy., Pezzali M; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy., Spaggiari L; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Division of Thoracic Surgery, European Institute of Oncology-IRCSS, Via Ripamonti 435, 20141 Milan, Italy., Testa G; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy. Electronic address: Giuseppe.testa@ieo.it.
Source: Trends in molecular medicine [Trends Mol Med] 2022 Jan; Vol. 28 (1), pp. 67-78. Date of Electronic Publication: 2021 Dec 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 100966035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-499X (Electronic) Linking ISSN: 14714914 NLM ISO Abbreviation: Trends Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-499X
DOI:10.1016/j.molmed.2021.10.008